SUMMARY Previous studies have shown that ileal infusion of partially digested triglyceride inhibits jejunal motility. The partial digest used in those studies contained a mixture of glycerol, free fatty acid, mono-, di-, and triglycerides. In Part I of the present study we have separately infused emulsions containing either glycerol 3.1 g (n=6), oleic acid 9-6 g (n=6), triolein 10 g (n=12), or medium chain triglycerides 10 g (n=6) into the ileum and have recorded the effect this has on jejunal motility. Five further subjects received infusions of partial hydrolysates of corn starch 10 g and lactalbumin 7 g. Marked inhibition of jejunal pressure wave activity was seen after all three lipid infusions, per cent activity falling from a control of 37-7 (7.7) to 6-2 (2 1) and 22.4 (8.2)% 30 min after completing the oleic acid and triolein infusions respectively, and from a control value of 39.5 (4.1) to 17.7 (4.7) after MCTs (all p<005). No significant fall occurred after infusion of glycerol, protein or carbohydrate. All three lipid infusions raised plasma concentrations of neurotensin, enteroglucagon and peptide YY equally effectively, although only the rise in peptide YY correlated significantly with the inihibition ofjejunal pressure wave activity (r=0 80, n=6, p<OO5). In Part II of this study six subjects received a 3 ml/min jejunal infusion of an isotonic carbohydrate saline solution followed after three hours by a similar infusion of a partial digest of lipid. During each infusion flow and transit time was measured by marker and dye dilution. Jejunal infusion of the carbohydrate-saline solution was associated with low jejunal flow, 4.7 (1.0) ml/min and a mean transit time through the 50 cm study segment of 36.5 (7 1) min. By contrast jejunal infusion of partially digested triglyceride was associated with a markedly increased flow, 9.0 (1-2) ml/min, a fall in mean transit time to 20.3 (2.6) min and significant rises in pancreaticobiliary secretions. Jejunal triglyceride also increased the incidence of prolonged high amplitude jejunal pressure waves in four of six subjects. These studies suggest that there are important differences in the jejunal response to ileal versus jejunal lipid. While long and median chain free fatty acids infused into the ileum exert an inhibitory effect on jejunal motility, when infused directly into the jejunum partially digested triglyceride accelerates transit, increases jejunal flow and subtly alters the pattern of jejunal contractions.
lleal brake mental model of steatorrhoea in man we have previously shown that an ileal infusion of 10 g of partially digested triglyceride produces an inhibitory effect on jejunal motility and delays transit through the upper small intestine,' an effect which we have termed the 'ileal brake'. Other authors using very different methods have also reported inhibitory effects on gastric emptying and small bowel transit in man using an ileal infusion of undigested triglyceride2 and similar effects have, now been reported in animals.3 As our initial infusion was a mixture of undigested triglyceride as well as free fatty acid and substantial amounts of glycerol it was not possible to identify the chemical component responsible for the inhibition of jejunal motility. The aim of the present study was to characterise further the nature of the ileal stimulus initiating the 'ileal brake' by separately infusing the various components of the initial infusion. We also compared the effect of long chain triglycerides with medium chain triglycerides. These were of special interest, as they are much more rapidly hydrolysed and absorbed than long chain triglycerides,4 and would be expected to exert a more immediate effect if absorption is a necessary preliminary before fats can initiate the 'ileal brake' reflex. We also studied the effect of isotonic solutions of partial hydrolysates of corn starch and milk protein to determine the chemical specificity of this inhibitory reflex. Simultaneous measurements of the plasma concentrations of peptides known to be stored in the ileal mucosa and released by ingested lipid, i.e. neurotensin (NT), enteroglucagon (EG), and peptide YY (PYY) were performed with the aim of identifying a possible peptide mediator of the jejunal inhibition. Finally in separate studies in which partially digested triglyceride emulsion was infused into the jejunum we evaluated the differing jejunal response to ileal versus jejunal lipid.
Methods

SUBJECTS
After an overnight fast, 23 healthy volunteers, 13 men and 10 women, aged 20-39 years were intubated with one of two multilumen radioopaque polyvinylchloride tubes, which were passed through the pylorus under fluoroscopic control aided by a 10 g tungsten weight. Subsequent passage of the tubes through the small intestine was accelerated by inflating a small latex rubber balloon at their tip.
The study was divided into two parts. In Part 1 (17 subjects), the effects of various ileal infusions on jejunal motility were recorded, while in Part II (six subjects), the effect of jejunal infusion of fat or carbohydrate on jejunal flow and transit was studied.
All subjects gave their informed consent to take part in these studies which had the approval of the Brent District Ethical Committee, 25 February 1981. Radiation exposure was from fluoroscopy (<60 sec), skin entrance dose <1 rad, testes/ovaries <0-1 rad, and from '4C-PEG, <10 mrad for the small and large intestine.
Part I PROCEDU RES
A 6-lumen combined manometry and perfusion tube was passed until the proximal infusion port P1 ( Fig.  1) Figure 3 , glycerol being infused at one hour, oleic acid two and a half hours, and triolein five hours after the start of the study. In experiments 7-12 subjects received infusions of triolein and medium chain triglycerides, the two infusions being separated by three hours, three subjects receiving triolein first and three medium chain triglycerides. In experiments 13-17 they received either a partial digest of milk protein (solution 5) or a partial digest of corn starch (solution 6) followed after one and a half hours by the other infusion using an alternating order of infusion.
PREPARATION OF SOLUTIONS
Unless otherwise specified, chemicals used were mmol/l 4 *Medium chain triglycerides: 98 mmol/l trioctanoin and 19 mmol/1 tridecanoin (10 g), glycerol 188 mmol/1 (2.6 g), NaCI 29 mmol/l 5 Partial hydrolysate of lactalbumin 47 g/l (7 g) 6 Caloreen 67 g/l (10 g), NaCI 125 mmol/1
The total infused dose of the nutrient components is indicated in parentheses. All solutions were isotonic and were adjusted to pH 7-0 with 1 Mol/l NaOH before infusion at 5 ml/min for 30 minutes; * Once the tube was positioned, the jejunal infusion was started at 3 ml/min with an isotonic Caloreensaline solution (Caloreen 150 g/l, NaCl 82 mmol/l) which also contained 5 mmol/l sodium taurocholate. After an hour equilibration period BSP 50 mg was infused over 10 minutes as 60 ml solution containing 1-3 mmol/l BSP, lactulose 227 mmol/l, rendered isotonic by adding NaCI 33 mmol/l. The jejunal infusion thereafter reverted to 3 ml/min as before. Intestinal fluid aspirated through B was pooled in 5 minute aliquots until no further dye could be detected (usually two hours). The Caloreen-saline jejunal infusate was then replaced by a partial digest of soya bean triglyceride and after a further hour equilibration period the transit of BSP was again measured.
The partial digest of soya bean triglyceride was prepared by incubating 132 ml lipofundin 20% (Braun, Melsungen, W Germany) with pancreatin 6 g (Grade IV, Sigma Chemical Co., Poole, Dorset, UK), sodium taurocholate 0-88 g, NaCl 2.24 g and distilled water 268 ml at 37°C for two hours. The final emulsion was diluted as necessary with water until the osmolality reached 290 mosmol/l. The final concentrations were: partially hydrolysed triglyceride 66 g/l, lecithin 5 g/l, glycerol 90 mmol/l, sodium taurocholate 5 mmol/l, NaCl 96 mmol/l, and pancreatin 15 g/l.
ANALYTICAL METHODS Na+ concentrations were measured by flame photometry using a multichannel Technicon SMA Plus autoanalyser (Technicon Instruments Inc, Tarrytown, New York). '4C-PEG concentration was measured by liquid scintillation counting using a Beckman LS' 7500 counter (Beckman Instruments Inc, High Wycombe, UK), counting in the gel phase. Quench correction was made using the H number method.6 Bromosulphthalein was measured by diluting 200 il intestinal fluid with 4-8 ml 50 mmol/l NaOH containing 10 g/100 ml of the non-ionic detergent 'Brij 35', which effectively removed the non-specific absorbance of the opalescent fat emulsion. The resulting clear violet solutions were assayed for BSP using a Pye Unicam SP6-500 UV spectrophotometer (Pye Unicam, Cambridge, UK) with a 1 cm light path, measuring absorbance at 580 nm. Reproducibility was good, the coefficient of variation of repeated assays (CV) being 1.5% (n= 10).
Bilirubin was similarly assayed spectrophotometrically using the absorbance at 460 nm after clarifying the samples in 10 g/100 ml 'Brij 35', CV being 2% (n= 10). Amylase was measured from the amount of dye liberated after incubation with a commercially available starch dye tablet (Phadebas Amylase Test, Pharmacia Diagnostics, Uppsala, Sweden), CV was 1Spiller, Trotman, A drian, Bloom, Misiewicz, and Silk acceptable at 4% (n = 10). Osmolality was assessed by freezing point depression, using an Advanced Osmometer Model 3W (Advanced Instruments Inc, Mass, USA), a method which is strictly only valid for dilute aqueous solutions; thus the values obtained must be regarded as approximations applying only to the aqueous phase of the emulsions. Plasma concentrations of neurotensin, enteroglucagon, and peptide YY were assayed using previously published radioimmunoassays.'
INTRALUMINAI PRESSURE RECORDINGS
Intraluminal pressures were measured through side opening ports which were constantly perfused with water at 01l ml/min using a pneumohydraulic capillary infusion system, Model DIP3 (Mui Scientific, Mississauga, Canada) and connected to external pressure transducers (Consolidated Electrodynamics, England), their output being recorded on a multichannel pen recorder (Grass Model D, Grass Instrument Co, Mass, USA) at a paper speed of 1 cm/min, pen deflection being 1 mm/2-3 mmHg. The manometry tubes had an internal diameter of 1 mm and, at the infusion rate used, had a good dynamic response, end occlusion of the ports producing a brisk response of 16-45 mmHg/sec. In vivo this system recorded pressure events at 10 cycles/min without showing fusion or failure to return to baseline between pressure spikes. The pressure recordings were analysed manually in 30 minute epochs for the per centage of time that phasic pressure wave activity was present, excluding waves less than 10 mmHg. Records from J 1, J2, and J3 were averaged to give an overall assessment of jejunal motor activity. Recordings during the infusions were not analysed as J3 was being used to infuse saline and hence during these periods the records were not comparable. Records were independently analysed by two of the authors one of whom was unaware of the nature of the solutions being tested. These independent scores showed excellent correlation, r=0-97 (n=84 separate one hour records). The recordings from Part II were also analysed for the area under the curve yielding a motility index in mmHg.min.
CALCULATIONS AND STATISTICS
Intestinal flow past port B was calculated from the dilution of '4C-PEG using the steady state equation" applied to the 15cm mixing segment. Knowing flow and dye concentration it was possible to calculate the cumulative passage of dye past port B. The validity of these calculations was supported by the finding that on average 99-4 (6.2) % of the injected dose was accounted for during each transit measurement (n= 12). Mean transit time through the segment AB was expressed, as the time for 50% of the dye bolus to pass port B.
Results in the text are expressed as mean ± standard error of mean (SE). The significance of differences were assessed using the non-parametric Mann Whitney U and Wilcoxon's matched pairs signed rank tests for unpaired and paired data respectively. (Fig. 3) . At this time the inhibition seen after the oleic acid infusion was significantly greater than that seen after triolein (p<O.OS). In experiments 7-12 medium chain triglyceride infusion produced a rapid inhibitory effect (per centage activity falling from the control value of 39.5 (4.1) to 17 7 (4.7) % at 30 min). This inhibition completely disappeared within one to two hours of completing the infusion (Fig. 4) . The onset of the inhibitory effect after triolein was slower than after MCT infusion, maximum inhibition being seen in the second 30 minute period after completing the ileal infusion, per centage activity reaching a nadir of 15-9 (7.6). Recovery of activity was also slower, activity in the third 30 minute period after completing the ileal triolein infusion being 18-6 (7.7) compared with 46.8 (9.4) % during the corresponding period after MCT infusion (p<0.05).
In contrast with the ileal lipid infusions, infusion of the partial hydrolysates of corn starch and lactalbumin did not inhibit jejunal motility (solutions 5 and 6, experiments [13] [14] [15] [16] [17] (Table 2) There was no significant change in plasma NT during the one hour control period but as expected, oleic acid infusion was followed by a substantial rise in plasma NT, peak concentrations of 49-7 (2.0) pmol/l being reached 30 min after completing the ileal infusion, these peaks being significantly greater than the basal preinfusion values of 24-0 (1.5) pmol/l (p<0-05). Similar rises were seen after triolein and MCTs (Table 2 ). Ileal infusion of glycerol alone did not alter plasma NT nor did infusion of the carbohydrate or the protein hydrolysates. The release of EG and PYY by the other solutions tested closely paralleled the release of NT, as can be seen in Table 2 .
CORRELATION BETWEEN PEPTIDE RELEASE AND INHIBITION OF MOTILITY
Considering the six ileal test solutions it was apparent that those which released the three peptides also inhibited motility, there being a weak but significant correlation between the mean fall in per centage activity in the first hour and mean rise in plasma peptide concentrations at one hour being 0 48, 0 50, and 0-80 for NT, EG, and PYY respectively (n=6, only the correlation with PYY being significant p<0.05).
PART II: EFFECT OF JEJUNAL INFUSIONS ON JEJUNAL FLOW AND MOTILITY
Jejunal infusion of the Caloreen-saline solution was associated with low flow rate which averaged only 2-9 (0.6) ml/min in the second half of the one hour equilibration period. Flow rose significantly as the dye and lactulose appeared averaging 5 8 (1.0) ml/ min in the subsequent 30 min (p<005), declining significantly in the following 30 min period to 4*8 (1.0) ml/min (p<0.05). By contrast jejunal perfusion of partially digested lipid strikingly increased the flow rates, which reached 12-8 (4.0) ml/min in the second half of the one hour equilibration period, significantly greater (p<005) than that observed during Caloreen infusion. Arrival of the dye was not associated with any noticeable further increase in flow, which averaged 9.4 (1.6) ml/min and 10.7 (1.4) ml/min in the two successive 30 minute intervals after the dye appeared in the aspirate.
Considering The long chain oleic acid (C18) and the medium chain caproic acid (C8, the major component of the medium chain triglycerides) were equally inhibitory and in both cases the effect appeared to last less than two hours. This rapid reversal of inhibition may reflect rapid absorption of these lipids from the lumen. Recovery of activity after triolein infusion was slower, perhaps because our ileal infusions diluted luminal lipase and thus impaired hydrolysis and absorption which in these circumstances is slower for triolein than for medium chain triglycerides.4 As luminal levels of lipid were not measured, however, this must remain speculative.
Our use of a non-random order of perfusion in the first six experiments raises the possibility of a carry over effect. We choose this order as the most economical study design because in pilot studies it was apparent that while glycerol produced little or no effect and the effect of oleic acid was readily reversible, the effect of triolein was the most long lasting. Thus we believe that the sequence used minimised the chances of carry over effects. It seems unlikely that the slower recovery of motor activity after triolein in experiments 1-6 was caused by a carry over effect as a similar time course was noted in the three studies (experiments 7, 9, and 11) in which triolein was infused as the first infusate. We cannot exclude the possibility that some of the lipid infusion reached the colon but think that it is unlikely that substantial amounts did because our subjects did not experience diarrhoea or abdominal cramps as have been observed during colonic infusion of oleic acid." Even if some did, it is unlikely that this would have altered small bowel motility because when 12 g of oleic acid was directly infused into the colon there was no change in ileal motility."
The ileal infusion of the protein hydrolysate did not affect jejunal percentage activity nor was there any significant inhibitory effect seen after ileal infusion of Caloreen (10 g ). This lack of effect may, however, merely reflect an inadequate dose of carbohydrate, since when we subsequently infused a further three subjects with 15 g of Caloreen they all showed an obvious inhibition of motility when compared with the one hour control period, percentage activity being 23.9, 47-8, and 58 v 2-9, 21-9, and 31-7% respectively. Unfortunately as administration of this larger dose was associated with right iliac fossa discomfort and nausea, symptoms not seen with the other infusions, we did not think it reasonable to pursue this further. Just why 15 g of partially digested starch produced pain is uncertain, but these glucose oligomers are rapidly hydrolysed to glucose producing a markedly hypertonic solution whose osmotic effect may induce substantial water secretion and pain because of associated intestinal distention. In these same three studies we did note substantial rises in NT (90, 78, and 96 pmol/l), EG (540, 480, and 360 pmol/l), but not PYY (15, 18 , and 11 p;mol/l) at 1 h.
It is possible therefore that lipid is not the only nutrient capable of eliciting the 'ileal brake' but, using our method larger doses of carbohydrate could not be readily studied.
Some comment is necessary here on the fat concentration in our test solutions. The initial partial digest' was an attempt to approximate postprandial ileal contents in marked steatorrhoea and hence contained pancreatin, bile salts 5 mmol/l and partially digested fat (66 g/l). In the present studies the ileal infusate was diluted by endogenous secretions and by the 5 ml/min saline infusion via J3, giving an estimated ileal luminal concentration about half that infused -that is, 33 g/l. How closely this mimics the ileal contents in the various diseases characterised by steatorrhoea is uncertain, but it lies within the range (26.0 (6.5) mg/ml, mean (SE)) found postprandially in the ileum of patients with modest steatorrhoea due to vagotomy and gastroenterostomy.'2 Ileal fat concentrations have not been directly measured in other conditions but when stool output is substantial, faecal composition should tend to approximate to caecal contents and in these circumstances patients with pancreatic steatorrhoea have faecal fat concentrations of 100-240 g/l. 13 This suggests that terminal ileal concentrations could well reach 33 g/l in severe steatorrhoea.
When comparing the different forms of lipid we choose to use equicaloric rather than equimolar doses as by analogy with the control of gastric emptying'4 we anticipated that the calorie content of our emulsions would be the most important factor influencing their inhibitory effect. This was indeed supported by our finding that 73 mmol/l of triolein exerted a similar degree of inhibition as 223 mmol/l oleic acid and approximately 117 mmol/l medium chain triglycerides. In testing the effect of our partial digests of starch and protein we used the most concentrated solutions which were tolerated without undue abdominal discomfort but it should be noted that these had a lower calorie content than the lipid emulsions so that no precise statement can be made about the relative effectiveness of these forms of nutrients without further dose response studies using lower calorie loads.
The lipid emulsions tested in the present study, like those used previously,' contained 66 g/l of lipid and 5 mmol/l Nataurocholate. Owing to the use of 20% Lipofundin in the present study rather than 10% Lipofundin used previously, however, there were differences in concentrations of lecithin (5 g/l instead of 10 g/l), glycerol (90 mmol/l instead of 181 mmol/l), NaCl (96 mmol/l instead of 37 mmol/l), and Pancreatin (15 g/l instead of 5 g/l). However to the faster dye transit we observed. Stimulation of propulsive activity has recently been reported in the ileum in response to boluses of short chain fatty acids27 but as we did not measure ileal motility we cannot comment on the ileal response to long chain fatty acids nor whether such a response is a generalised one seen with all fatty acids.
Combining the results of the two parts of our study it would appear that in health after a mixed meal the outpouring of pancreatic and biliary secretions produces a high flow in the jejunum. Flow will fall further down the small intestine as hydrolysis is followed by rapid absorption of nutrients, water, and electrolytes. Where mucosal disease prevents or inhibits absorption substantial amounts of unabsorbed nutrients will enter the distal ileum thereby activating the ileal brake effect and delaying jejunal transit allowing more time for absorption to take place.
The studies reported here have further characterised the nature of the stimulus activating the 'ileal brake'. They suggest that long and medium chain free fatty acids stimulate the ileum to exert an inhibitory effect on the motility of the proximal small intestine. This could be mediated via the activation of specific receptors or could be caused by the non-specific detergent effect of free fatty acids. Our studies do not permit differentiation between these possibilities which will probably require more systematic doseresponse studies in an animal model. Circumstantial evidence supports the idea that peptide YY could be at least partly responsible for this effect but definite proof must await further studies. 
